Roche Holding AG (RHHBY)
52.75
-0.44
(-0.83%)
USD |
OTCM |
Sep 11, 16:00
Roche Price : 52.75 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 53.20 | 53.35 | 52.67 | 52.75 | 1.653M |
| Sep 10, 2026 | 52.99 | 53.53 | 52.90 | 53.19 | 1.489M |
| Sep 09, 2026 | 54.07 | 54.29 | 53.37 | 53.38 | 1.184M |
| Sep 08, 2026 | 54.24 | 54.42 | 53.87 | 54.07 | 1.301M |
| Sep 04, 2026 | 54.43 | 55.20 | 54.43 | 54.96 | 863861.0 |
| Sep 03, 2026 | 55.64 | 55.66 | 54.72 | 55.22 | 2.366M |
| Sep 02, 2026 | 53.94 | 54.28 | 53.59 | 53.83 | 3.493M |
| Sep 01, 2026 | 53.81 | 54.04 | 53.07 | 53.09 | 5.094M |
| Aug 31, 2026 | 54.85 | 54.85 | 53.36 | 53.70 | 6.501M |
| Aug 28, 2026 | 55.88 | 55.89 | 55.08 | 55.19 | 1.071M |
| Aug 27, 2026 | 56.59 | 56.65 | 56.20 | 56.39 | 732137.0 |
| Aug 26, 2026 | 57.30 | 57.52 | 56.81 | 56.89 | 902040.0 |
| Aug 25, 2026 | 57.80 | 58.47 | 57.64 | 58.47 | 1.005M |
| Aug 24, 2026 | 57.48 | 57.72 | 57.40 | 57.47 | 1.725M |
| Aug 21, 2026 | 57.37 | 58.60 | 57.37 | 58.10 | 3.291M |
| Aug 20, 2026 | 57.94 | 58.28 | 57.00 | 57.25 | 5.374M |
| Aug 19, 2026 | 56.47 | 58.41 | 56.47 | 58.20 | 2.203M |
| Aug 18, 2026 | 55.30 | 55.73 | 55.21 | 55.52 | 4.587M |
| Aug 17, 2026 | 54.87 | 55.43 | 54.55 | 54.61 | 1.843M |
| Aug 14, 2026 | 54.60 | 54.88 | 54.42 | 54.52 | 1.477M |
| Aug 13, 2026 | 56.19 | 56.22 | 55.38 | 55.49 | 2.552M |
| Aug 12, 2026 | 55.75 | 56.52 | 55.70 | 56.51 | 992141.0 |
| Aug 11, 2026 | 57.50 | 57.71 | 56.56 | 56.62 | 1.919M |
| Aug 10, 2026 | 57.09 | 57.62 | 57.06 | 57.43 | 1.028M |
| Aug 07, 2026 | 57.44 | 57.57 | 56.97 | 57.26 | 1.356M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 137.16 |
| AstraZeneca PLC | 160.17 |
| Merck & Co., Inc. | 143.93 |
| Pfizer Inc. | 27.72 |
| Eli Lilly & Co. | 1115.70 |
Price Related Metrics
| PE Ratio | 21.82 |
| PS Ratio | 4.422 |
| PEG Ratio | 0.7322 |
| Price to Free Cash Flow | 20.75 |
| Earnings Yield | 4.58% |
| Market Cap | 291.21B |
| PEGY Ratio | 0.6665 |
| Operating PE Ratio | 14.42 |
| Normalized PE Ratio | 18.29 |